- Home
- PUMP vs DAWN Comparison
PUMP vs DAWN Comparison
Compare PUMP & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PUMP | DAWN |
|---|---|---|
| Founded | 2007 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PUMP | DAWN |
|---|---|---|
| Price | $12.11 | $10.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 9 |
| Target Price | $12.29 | ★ $27.11 |
| AVG Volume (30 Days) | ★ 3.2M | 1.8M |
| Earning Date | 05-19-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.76 | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $1,269,158,000.00 | $158,182,000.00 |
| Revenue This Year | $0.93 | $47.48 |
| Revenue Next Year | $13.04 | $31.10 |
| P/E Ratio | $1,189.50 | ★ N/A |
| Revenue Growth | N/A | ★ 20.60 |
| 52 Week Low | $4.51 | $5.64 |
| 52 Week High | $13.25 | $13.20 |
Technical Indicators
Market Signals| Indicator | PUMP | DAWN |
|---|---|---|
| Relative Strength Index (RSI) | 59.92 | 44.23 |
| Support Level | $10.26 | $10.07 |
| Resistance Level | $13.25 | $10.68 |
| Average True Range (ATR) | 0.87 | 0.66 |
| MACD | 0.00 | -0.17 |
| Stochastic Oscillator | 56.63 | 11.26 |
Price Performance
Historical ComparisonAbout PUMP ProPetro Holding Corp.
ProPetro Holding Corp is a Texas-based oilfield services company. It provides hydraulic fracturing, wireline, and other complementary services to oil and gas companies engaged in the exploration and production of North American oil and natural gas resources. The company focused on the Permian Basin. The operating segments of the company are hydraulic fracturing which generates key revenue, wireline, cementing, and power generation service.
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.